skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Toxicity of taurolithocholate as a model for cholestasis in the rat liver

Conference · · J. Nucl. Med.; (United States)
OSTI ID:6762056

A model was investigated to facilitate the detection of mild diffuse liver disease. The introduction of sodium taurolithocholate(TLC) into the bloodstream of rats has been shown to produce cholestasis. This study was undertaken to assess the available control over the cholestatic effect with regulated TLC. The rat model then utilized to evaluate the ability of Tc-99m Hepatolite (IDA) to predict the extent of cholestasis in mildly diseased liver. 27 Charles River rats (300-350 grams) were studied. Pentabarbital was used for anesthesia and body temperature was maintained between 37.5 and 38.5/sup 0/C. A standard tracheostomy and jugular vein and carotid artery cannulation was performed for the administration of the TLC and IDA and for blood sampling. The common bile duct was cannulated for bile collection. Bile was collected for 10 minutes post surgery and then the TLC, or just vehicle for controls, was administered. 5 minute bile collections continued for 60 minutes and blood samples were collected 9 times during the same hour period. The cumulative percent dose of IDA in the bile was found to be controllable while the blood clearance was not appreciably different for the doses investigated. Doses of 5.0, 3.75, 2.75 and 0 micromoles of TLC per 100 grams of rat weight were found to yield a 85%, 68% 45% and 15% cholestatic effect. The 45% cholestasis is reproducible and most clinically interesting the authors' studies. The 15% cholestasis for the control rats demonstrates a baseline cholestasis from the surgical intervention.

Research Organization:
Univ. of Colorado Health Sciences Center, Denver, CO
OSTI ID:
6762056
Journal Information:
J. Nucl. Med.; (United States), Vol. 26:5
Country of Publication:
United States
Language:
English

Similar Records

Monohydroxy bile salt sulfates: tauro-3 beta-hydroxy-5-cholenoate-3-sulfate induces intrahepatic cholestasis in rats
Journal Article · Thu Sep 01 00:00:00 EDT 1983 · Gastroenterology; (United States) · OSTI ID:6762056

UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats
Journal Article · Tue Nov 15 00:00:00 EST 2016 · Toxicology and Applied Pharmacology · OSTI ID:6762056

Endogenous glucocorticoids exacerbate cholestasis-associated liver injury and hypercholesterolemia in mice
Journal Article · Thu Sep 01 00:00:00 EDT 2016 · Toxicology and Applied Pharmacology · OSTI ID:6762056